GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » EV-to-Revenue

Imricor Medical Systems (ASX:IMR) EV-to-Revenue : 114.81 (As of May. 16, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Imricor Medical Systems's enterprise value is A$105.63 Mil. Imricor Medical Systems's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.92 Mil. Therefore, Imricor Medical Systems's EV-to-Revenue for today is 114.81.

The historical rank and industry rank for Imricor Medical Systems's EV-to-Revenue or its related term are showing as below:

ASX:IMR' s EV-to-Revenue Range Over the Past 10 Years
Min: -8.65   Med: 84.08   Max: 252.13
Current: 114.83

During the past 6 years, the highest EV-to-Revenue of Imricor Medical Systems was 252.13. The lowest was -8.65. And the median was 84.08.

ASX:IMR's EV-to-Revenue is ranked worse than
96.14% of 829 companies
in the Medical Devices & Instruments industry
Industry Median: 3.27 vs ASX:IMR: 114.83

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-16), Imricor Medical Systems's stock price is A$0.45. Imricor Medical Systems's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01. Therefore, Imricor Medical Systems's PS Ratio for today is 75.00.


Imricor Medical Systems EV-to-Revenue Historical Data

The historical data trend for Imricor Medical Systems's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems EV-to-Revenue Chart

Imricor Medical Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 112.09 245.90 123.84 44.17 120.23

Imricor Medical Systems Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only 123.84 - 44.17 - 120.23

Competitive Comparison of Imricor Medical Systems's EV-to-Revenue

For the Medical Devices subindustry, Imricor Medical Systems's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imricor Medical Systems's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imricor Medical Systems's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Imricor Medical Systems's EV-to-Revenue falls into.



Imricor Medical Systems EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Imricor Medical Systems's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=105.626/0.92
=114.81

Imricor Medical Systems's current Enterprise Value is A$105.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Imricor Medical Systems's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imricor Medical Systems  (ASX:IMR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Imricor Medical Systems's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.45/0.006
=75.00

Imricor Medical Systems's share price for today is A$0.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imricor Medical Systems EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Imricor Medical Systems (ASX:IMR) Business Description

Traded in Other Exchanges
N/A
Address
400 Gateway Boulevard, Burnsville, MN, USA, 55337
Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems (ASX:IMR) Headlines

No Headlines